Espinoza Octavio (CIK 1905248) reported 45 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy LGND (16,179 shares), Buy LGND (2,074 shares), Buy LGND (2,869 shares), Buy LGND (7,171 shares), Buy LGND (3,348 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 16,179 | $854,898 |
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 2,074 | $145,263 |
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 2,869 | $159,947 |
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 7,171 | $410,325 |
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 3,348 | $230,142 |
| 2026-08-14 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 31,641 | $9.2M |
| 2026-07-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 17 | $2,732 |
| 2026-05-28 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 764 | $48,606 |
| 2026-05-28 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 972 | $51,360 |
| 2026-03-27 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 4,933 | $0 |
| 2026-03-13 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 2,405 | $222,823 |
| 2026-03-13 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 3,057 | $687,825 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 1,607 | $93,993 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Buy | 466 | $37,616 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 699 | $138,898 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 53 | $10,604 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 698 | $140,361 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 950 | $191,644 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 697 | $141,345 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 668 | $136,025 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 743 | $152,122 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 1,457 | $299,836 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 1,588 | $328,541 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 2,457 | $510,835 |
| 2026-03-06 | LIGAND PHARMACEUTICALS INC (LGND) | Chief Financial Officer | Sell | 3,413 | $712,634 |
Source: SEC Form 4 filings · as of 2026-08-14